ClinicalTrials.Veeva

Menu

Future Patient - Telerehabilitation of Patients With Atrial Fibrillation ((FP-AF))

A

Aalborg University

Status

Enrolling

Conditions

Atrial Fibrillation

Treatments

Device: Telerehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT06101485
N-20220056

Details and patient eligibility

About

This project has focus on patients with atrial fibrillation testing a telerehabilitation program for patients with atrial fibrillation.

Full description

The overall aim of the FP-AF program is to increase quality of life by giving the patients and relatives more knowledge about atrial fibrillation, its symptoms, and the issues of living with atrial fibrillation in everyday life. The specific aims are to individualize the rehabilitation process and help the patients and relatives develop their own self-management strategies using their own clinical data and their enhanced knowledge about AF.

Enrollment

208 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with atrial fibrillation
  • Adults over 18 years
  • Living in Skive, Viborg or Silkeborg Municipalities
  • Living at home and capable of caring for themselves
  • Have basic computer skills or having a relative/friend with basic computer skills

Exclusion criteria

  • Pregnancy
  • Refusal or inability to cooperate; or patient not does not speak, read or understand Danish
  • Life expectancy less than a year

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

208 participants in 2 patient groups

Telerehabilitation group
Experimental group
Description:
The telerehabilitation group (n=104) will participate in the FP-AF program for 16 weeks. The program is administered by the AF clinics and the healthcare centers (HC) in Viborg, Skive and Silkeborg Municipalities. After enrollment, the patients will have an individual meeting with the project nurse. Here the patient (and relatives, if necessary) will be instructed in the use of the technologies and an individual plan will be formulated for the AF patient's telerehabilitation. After participation in 16 weeks the patients start a 12 weeks follow-up period, where they will only measure steps and have access to the Heartportal on their own devices.
Treatment:
Device: Telerehabilitation
Conventional rehabilitation
No Intervention group
Description:
The control group (n=104) will follow the conventional care regime in the AF clinic and will not have contact to the project nurse. When the AF patients are in a stable condition, they will be followed by their general practitioner (GP). The control group will be in the study for 28 weeks.

Trial contacts and locations

1

Loading...

Central trial contact

Birthe Dinesen, MSc, Ph.D; Dorthe Svenstrup, MD, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems